Tobias Deuse

Tobias Deuse, MD, is a co-founder of Shinobi Therapeutics since February 2023 and serves as the Professor and Interim Chief of the Division of Adult Cardiothoracic Surgery at the University of California, San Francisco, holding the Julien I.E. Hoffman, M.D. Endowed Chair in Cardiac Surgery since December 2015. Tobias Deuse earned a Doctor of Medicine degree from Ludwig-Maximilians-Universität München between 2000 and 2002, having previously completed a Doctorate in Medicine at The Julius Maximilians University of Würzburg from 1994 to 2000, and a Pre-Diploma in Physics at the University of Stuttgart from 1992 to 1994.